Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Fast Is The Diuretics Market Expected to Grow Between 2025 And 2029?
In the past few years, the diuretics market has seen a consistent increase in its size. It is projected to expand from $0.74 billion in 2024 to $0.77 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.5%. Factors contributing to this growth during the historical period include the widespread occurrence of chronic diseases, an aging population, established clinical guidelines, pharmaceutical innovation, and a surge in obesity.
What Growth Rate Is Anticipated for the Diuretics Market in the Coming Years?
The market for diuretics is projected to experience consistent expansion in the coming years, reaching a total value of $0.89 billion in 2029, with a compound annual growth rate (CAGR) of 3.5%. This growth during the forecast period is largely due to an increase in hypertension and heart failure cases, expansion in emerging markets, governmental efforts, and emphasis on preventive healthcare. Noteworthy trends to expect during this period entail personalized medicinal approaches, groundbreaking pharmaceutical innovations, telehealth along with remote patient monitoring, and adoption of digital health solutions.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2439&type=smp
Who Are the Leading Companies in the Diuretics Market?
Major companies operating in the diuretics market include Merck & Co. Inc., Meda Manufacturing GmbH, Pfizer Inc., GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Aton Pharma Inc., Boehringer Ingelheim International GmbH, Novartis AG, Teva Pharmaceutical Industries Ltd., Sanofi-aventis U.S. LLC, Centaur Pharmaceuticals Pvt Ltd, Validus Pharmaceuticals LLC, Actavis Generics, Paddock Laboratories LLC, Perrigo Pharmaceutical Company, H. Lundbeck Inc., Oak Pharmaceuticals Inc., Akron Pharmaceuticals Inc., Salix Pharmaceuticals Inc., Alembic Pharmaceuticals Limited, Aurobindo Pharma Limited, IPCA Laboratories Limited, Jubilant Cadista Pharmaceuticals Limited, Mylan N.V., Princeton Laboratories Inc., Sciegen Pharma Limited, Unichem Laboratories Limited, AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Cipla Ltd, F Hoffmann-La Roche Ltd, Fresenius Kabi AG, Sandoz International GmbH, Sun Pharmaceutical Industries Ltd, Zydus Lifesciences Ltd., Amneal Pharmaceuticals LLC, Apotex Inc.
What Are the Key Drivers of the Diuretics Market?
The escalation in renal and kidney disease cases propels the growth of the diuretics market. As the kidney loses its normal functioning in such situations, the demand for water pills (diuretic medicines) increases to ensure adequate urine flow. The upsurge in kidney ailments can be traced back to lifestyle changes, like the intake of food high in calcium and other minerals that are unhealthful. For example, data from the Centers for Disease Control and Prevention (CDC), a US-based public health organization, showed in May 2024 that an estimated 14% or about 35.5 million of American adults are suspected to have chronic kidney diseases. Thus, the rising kidney and renal disorder cases fuel the expansion of the diuretics market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=2439&type=smp
What Are the Key Market Segments in the Diuretics Industry?
The diuretics market covered in this report is segmented –
1) By Type: Osmotic Diuretics, Carbonic Anhydrase Inhibitors, Loop Diuretics, Thiazides And Thiazide-Like Diuretics, Aldosterone Antagonists
2) By Distribution: Hospital Pharmacies, Independent Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies
3) By Application: Hypertension, Glaucoma, Heart Failure, Kidney Stones
Subsegments:
1) By Osmotic Diuretics: Mannitol, Glycerin, Urea
2) By Carbonic Anhydrase Inhibitors: Acetazolamide, Dorzolamide, Brinzolamide
3) By Loop Diuretics: Furosemide, Bumetanide, Torsemide, Ethacrynic Acid
4) By Thiazides And Thiazide-Like Diuretics: Hydrochlorothiazide, Chlorthalidone, Indapamide, Metolazone
5) By Aldosterone Antagonists: Spironolactone, Eplerenone
What Are the Latest Trends in the Diuretics Market?
Major firms in the diuretics market are concentrating on creating novel products, such as prescription drugs, to improve treatment outcomes and minimize side effects for patients suffering from conditions like hypertension and heart failure. Prescription drugs are those that can only be purchased with a medical prescription, ensuring their correct use for specific health conditions under expert guidance. For instance, Glenmark Pharmaceuticals Limited, an Indian pharma company, introduced a generic version of the diuretic Bumetanide Injection for treating fluid retention and swelling due to congestive heart failure and other circumstances, in January 2023. This product comes in two preparations: 1 mg/4 mL single-dose vials and 2.5 mg/10 mL multi-dose vials, both containing a concentration of 0.25 mg/mL. The injection is employed to effectively manage edema (fluid retention) resulting from conditions like congestive heart failure, liver disease, and kidney disease, advocating increased urine output to relieve symptoms such as swelling and difficulty breathing.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/diuretics-drugs-global-market-report
What Are the Key Regional Markets in the Diuretics Industry?
North America was the largest region in the diuretics market in 2023. The Middle East is expected to be the fastest-growing region in the diuretics market during the forecast period. The regions covered in the diuretics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2439
This Report Delivers Insight On:
1. How big is the diuretics market, and how is it changing globally?
2. Who are the major companies in the diuretics market, and how are they performing?
3. What are the key opportunities and risks in the diuretics market right now?
4. Which products or customer segments are growing the most in the diuretics market?
5. What factors are helping or slowing down the growth of the diuretics market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model